evidencegaps
Primary study · included by 1 review

Intravenous selenium to prevent oral mucositis in patients with lymphoma or myeloma undergoing high-dose therapy followed by autologous hematopoietic cell transplantation: A double-blind randomized trial.

Orvain 2025 · Orvain Corentin, Giltat Aurélien, Klémencie Marion, et al. · Journal of Clinical Oncology · 2025

Included by

Selenium supplementation for preventing cancer therapy-related toxicities: a systematic review and meta-analysis of clinical trials.
Non-Cochrane · intervention · 2026 · cited as Orvain 2025 · Supplementary Table S12; reference 17 (conference abstract, supplementary evidence)

The review does not say which of its outcomes this study informs.

1 including review in total.